Since the start of the rate hike cycle in 2022, regional business cycles have weakened, earnings growth has stagnated (S&P 500 2021-2024E EPS: $208-$225, ~2.5% CAGR), and the market has moved sideways averaging near our price target of 4,200 (2022 avg: ~4,100; 2023 avg: ~4,250). Equity concentration reached levels not seen since 1970s with a very narrow leadership, which is…
J.P. Morgan’s Quant Team 2024 U.S. Equity Outlook
A financial market resource for the every-day investor and trader.
-
Weight Of The Evidence Pushes Markets In One Direction
Seth Golden, , Research Reports, 0
Well, it definitely got worse before it got better, or got flat for the week. This was largely our...
-
Managing VIX-Leveraged ETPs Through Earnings Season, Political Strife And A Frothy Market
Seth Golden, , Research Reports, 0
In 2015, I penned my first article on the subject matter surrounding VIX-leveraged ETF/ETNs. Back then, as if it...
-
Morgan Stanley Biotechnology Team: Year-End Vaccine Probable
Seth Golden, , Research Reports, 0
Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is...
-
Merrill Lynch CIO Market Outlook
Seth Golden, , Research Reports, 0
Good Sunday and as a reminder, our weekly Research Report issuance will begin again on December 9, 2019. This...
-
Weekly State of the Market: Busting Myths With Discipline
Seth Golden, , Research Reports, 0
Remember that valuation is only expensive relative to history, and irrespective of the future! If I might introduce you...
-
Weekly State of the Market: Buy The Dip… And How?
Seth Golden, , Research Reports, 0
Thank you for joining us for this week’s State of the Market. My voice is back, to a greater...
-
-
Morgan Stanley’s Weekly Warm-up: Fire or Ice?
Seth Golden, , Research Reports, 0
With the S&P 500 up more than 20% YTD, alpha has been harder to generate this year. Having the...